Skip to content

Medical Innovation Meets Regulatory Excellence

What do U.S. tariffs mean for Canadian medical device companies?

Updated April 8, 2025 – The U.S. tariffs imposed on goods from Canada presents significant challenges for medical device companies. Despite lobbying by industry associations on both sides of the border, medical devices — including raw materials and parts — are not exempt. In response, Canada has implemented retaliatory tariffs on a wide range of

Navigating MDEL Modernization: What You Need to Know

January 27, 2025 – It’s MDEL Annual Licence Review (ALR) season and, for Medical Device Establishment Licence (MDEL) holders, Health Canada’s ongoing modernization of the MDEL framework brings changes that may affect your regulatory compliance status. Understanding these changes is crucial for ensuring your organization remains compliant with the latest regulatory amendments. Health Canada is

2 Items